SHIKARI® Q-CAN


Enzyme immunoassay for the quantitative determination of Canakinumab (Ilaris®) in human serum and plasma

Enzyme immunoassay for the quantitative determination of Canakinumab (Ilaris®) in serum and plasma. The Matriks Biotek Shikari Canakinumab ELISA has been especially developed for the quantitative analysis of Canakinumab in serum and plasma samples.



Click the diagram to see bigger



Required Volume (µl) 10
Total Time (min) 70
Sample Serum, plasma
Sample Number 96
Detection Limit (ng/mL) 30
Spike Recovery (%) Between 85-115
Shelf Life (year) 1

SHIKARI® S-ATCAN


Enzyme immunoassay for the qualitative determination of specific antibodies to Canakinumab (Ilaris®) in human serum and plasma

The Matriks Biotek Antibody to Canakinumab (Ilaris®) Enzyme-Linked-ImmunoSorbentAssay (ELISA) Kit is intended for the qualitative determination of antibodies to Canakinumab (Ilaris®) in serum and plasma. It is for professional use only.





Required Volume (µl) 10
Total Time (min) 140
Sample Serum, plasma
Sample Number 96
Detection Limit (ng/mL) + / -
Spike Recovery (%) -
Shelf Life (year) 1

MATRIKS BIOTECHNOLOGY CO., LTD

Gazi Üniversitesi Gölbaşı Yerleşkesi Teknoplaza Binası,
(B Blok Zemin Kat BZ17),
06830,
Gölbaşı/ANKARA/TÜRKİYE

Contact Details

Telephone: +90 (312) 485 42 94
Intl.calls&Whatsapp: +90 (546) 485 42 94
Email: info@matriksbiotek.com
Email: order@matriksbiotek.com
Fax: +90 (312) 485 11 87